Study Using Hyperpolarized 13C-Pyruvate Magnetic Resonance Spectroscopic Imaging in Patients With Pancreatic Cysts Undergoing Surgical Resection
Pancreatic Cyst
About this trial
This is an interventional diagnostic trial for Pancreatic Cyst
Eligibility Criteria
Inclusion Criteria: Patients ≥ 18 years old. Patients under 18 are excluded due to their potential inability to understand and consent independently to the methods required for the study drug use and its potential risks and benefits. Patients with pancreatic cyst/s Patients who will undergo surgical resection (or cyst wall biopsy) of pancreatic cysts Patients able to understand and willing to sign a written informed consent document Both English-speaking and non-English-speaking patients are eligible for participation Exclusion Criteria: Contraindication to MRI Electrically, magnetically, or mechanically activated implants that would preclude MRI Allergy to Gadavist IV contrast History of cardiac arrhythmias Pregnancy or breastfeeding women Women of child-bearing age that are sexually active and not using birth control Cognitively impaired individuals Weight above 260 pounds (lbs)
Sites / Locations
- M D Anderson Cancer CenterRecruiting
Arms of the Study
Arm 1
Experimental
Hyperpolarized 13C-Pyruvate Magnetic Resonance Spectroscopic Imaging
Participants will have the HP-MR scan within the 4 weeks before your scheduled surgery. Hyperpolarized C-Pyruvate will be injected by vein during the scan. Your vital signs (temperature, blood pressure, heart rate and respiration [breathing]) will be monitored during the scan. The estimated time of the scan is a couple of minutes, but you may be in the room of the MRI for up to 30 minutes for preparation. The entire process of obtaining the MRI (and possible blood draw) may be up to half of a work day (not including your personal travel time).